- Home
- GORV vs RADX Comparison
GORV vs RADX Comparison
Compare GORV & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GORV
- RADX
- Stock Information
- Founded
- GORV 1976
- RADX 2021
- Country
- GORV United States
- RADX Australia
- Employees
- GORV N/A
- RADX N/A
- Industry
- GORV Retail-Auto Dealers and Gas Stations
- RADX
- Sector
- GORV Consumer Discretionary
- RADX
- Exchange
- GORV Nasdaq
- RADX NYSE
- Market Cap
- GORV 25.3M
- RADX 32.5M
- IPO Year
- GORV 2015
- RADX N/A
- Fundamental
- Price
- GORV $0.24
- RADX $4.25
- Analyst Decision
- GORV Hold
- RADX Strong Buy
- Analyst Count
- GORV 2
- RADX 2
- Target Price
- GORV $2.00
- RADX $13.50
- AVG Volume (30 Days)
- GORV 2.3M
- RADX 22.4K
- Earning Date
- GORV 08-15-2025
- RADX 02-26-2025
- Dividend Yield
- GORV N/A
- RADX N/A
- EPS Growth
- GORV N/A
- RADX N/A
- EPS
- GORV N/A
- RADX N/A
- Revenue
- GORV $767,257,000.00
- RADX $204,609.00
- Revenue This Year
- GORV $15.65
- RADX N/A
- Revenue Next Year
- GORV $20.54
- RADX N/A
- P/E Ratio
- GORV N/A
- RADX N/A
- Revenue Growth
- GORV N/A
- RADX N/A
- 52 Week Low
- GORV $0.13
- RADX $3.50
- 52 Week High
- GORV $3.56
- RADX $50.82
- Technical
- Relative Strength Index (RSI)
- GORV 48.60
- RADX N/A
- Support Level
- GORV $0.22
- RADX N/A
- Resistance Level
- GORV $0.26
- RADX N/A
- Average True Range (ATR)
- GORV 0.02
- RADX 0.00
- MACD
- GORV 0.00
- RADX 0.00
- Stochastic Oscillator
- GORV 51.29
- RADX 0.00
About GORV Lazydays Holdings Inc.
Lazydays Holdings Inc operates recreational vehicle dealerships. It provides products and services for RV owners and outdoor enthusiasts. The company generates revenue by providing a full spectrum of RV products: New and pre-owned RV sales, RV parts and services, financing and insurance products, third-party protection plans, after-market parts and accessories, and RV camping facilities.
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.